LTR Pharma Ltd News

LTR Pharma Ltd: Reinstatement to quotation

Jun 7 09:39

LTR Pharma Ltd: SPONTAN achieves positive clinical study results

Jun 7 09:39

LTR Pharma Ltd: Suspension from Quotation

Jun 6 08:42

LTR Pharma Ltd: Trading Halt

Jun 4 07:11

LTR Pharma Ltd: Response to ASX Price Query

May 22 13:44

LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29 07:38

LTR Pharma Ltd: Notification regarding unquoted securities - LTP

Apr 18 14:59

LTR Pharma Ltd: Final Patients dosed in SPONTAN pivotal study

Mar 25 06:05

LTR Pharma Ltd: First patients dosed in SPONTAN pivotal study

Mar 19 05:45

LTR Pharma Ltd: Investor Presentation

Mar 18 05:32

LTR Pharma Ltd: Appendix 4D and Half Yearly Report

Feb 28 05:10

LTR Pharma Ltd: Recruitment commences for SPONTAN Clinical Study

Feb 19 05:11

LTR Pharma Ltd: Notification regarding unquoted securities - LTP

Feb 16 06:15

LTR Pharma Ltd: SPONTAN Achieves Key Manufacturing Validation

Feb 6 05:23

LTR Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 30 05:16

LTR Pharma Ltd: Response to ASX Query Letter

Dec 19, 2023 14:53

LTR Pharma Ltd: Positive Clinical Data presented at the WMSM in Dubai

Dec 18, 2023 06:26

LTR Pharma Ltd: Initial Director's Interest Notice - M McGuire

Dec 13, 2023 07:35

LTR Pharma Ltd: Initial Director's Interest Notice - J Chick

Dec 13, 2023 07:32

LTR Pharma Ltd: Initial Director's Interest Notice - L Rodne

Dec 13, 2023 07:31